399441 生物医药
已收盘 03-20 15:00:00
资讯
新帖
简况
聚焦钢铁、化工、生物医药等重点行业 河北将培育一批工业大模型
滚动播报 · 03-21 06:57
聚焦钢铁、化工、生物医药等重点行业 河北将培育一批工业大模型
派格生物医药-B涨超10%
每日经济新闻 · 03-20 10:51
派格生物医药-B涨超10%
【券商聚焦】中国银河:“十五五”首次将生物医药列为国家新兴支柱产业,持续发力研发创新
金吾财讯 · 03-20 09:23
【券商聚焦】中国银河:“十五五”首次将生物医药列为国家新兴支柱产业,持续发力研发创新
中华医学会副会长杨宝峰:生物医药发展需要多学科交叉,AI也是助手
新浪财经 · 03-18
中华医学会副会长杨宝峰:生物医药发展需要多学科交叉,AI也是助手
派格生物医药-B(02565)与腾瑞制药达成派达康中国大陆独家商业化合作 商业化目标累计销售规模超过100亿元并获得约1.4亿港元权益金
智通财经 · 03-16
派格生物医药-B(02565)与腾瑞制药达成派达康中国大陆独家商业化合作 商业化目标累计销售规模超过100亿元并获得约1.4亿港元权益金
从“新兴”到“支柱” 生物医药产业能级跃升
中国经营网 · 03-14
从“新兴”到“支柱” 生物医药产业能级跃升
派格生物医药-B(02565)每手买卖单位将更改为50股H股
智通财经 · 03-10
派格生物医药-B(02565)每手买卖单位将更改为50股H股
派格生物医药-B(02565):派格生物新一代GLP-1(CR059)首次人体试验取得一个月临床观察结果
智通财经网 · 03-06
派格生物医药-B(02565):派格生物新一代GLP-1(CR059)首次人体试验取得一个月临床观察结果
兰州高新区生物医药产业冲刺首季“开门红”
每日甘肃网 · 03-02
兰州高新区生物医药产业冲刺首季“开门红”
四川双马:持续推进生物医药板块的深度布局与高质量发展
证券之星 · 02-26
四川双马:持续推进生物医药板块的深度布局与高质量发展
天辰生物医药再度递表港交所
智通财经 · 02-26
天辰生物医药再度递表港交所
生物医药企业Polaryx直接上市:市值1.24亿美元 9个月净亏749万美元
雷递 · 02-23
生物医药企业Polaryx直接上市:市值1.24亿美元 9个月净亏749万美元
生物医药企业Polaryx直接上市:市值1.26亿美元 9个月亏749万美元
雷递网 · 02-20
生物医药企业Polaryx直接上市:市值1.26亿美元 9个月亏749万美元
大兴机场临空区,国际生物医药园(二期)冲出正负零
新京报 · 02-14
大兴机场临空区,国际生物医药园(二期)冲出正负零
派格生物医药-B股价下跌5.54%,受板块走弱及利好兑现影响
经济观察网 · 02-14
派格生物医药-B股价下跌5.54%,受板块走弱及利好兑现影响
派格生物医药-B获纳入恒生综合指数 有望成为港股通标的
智通财经 · 02-14
派格生物医药-B获纳入恒生综合指数 有望成为港股通标的
成大生物(688739)披露拟参与设立5.02亿元生物医药产业投资基金,2月5日股价上涨0.39%
证券之星 · 02-05
成大生物(688739)披露拟参与设立5.02亿元生物医药产业投资基金,2月5日股价上涨0.39%
港股生物医药板块走高,诺诚健华、再鼎医药涨超4%,药明康德、药明生物等个股跟涨
老虎资讯综合 · 02-05
港股生物医药板块走高,诺诚健华、再鼎医药涨超4%,药明康德、药明生物等个股跟涨
2月2日长春高新跌6.14%,招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 02-02
2月2日长春高新跌6.14%,招商国证生物医药指数(LOF)C基金重仓该股
天溯计量:此次获奖项目是公司针对生物医药开展的具有原创性的计量装置研发与应用实践
证券之星 · 01-29
天溯计量:此次获奖项目是公司针对生物医药开展的具有原创性的计量装置研发与应用实践
加载更多
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"399441","market":"SZ","secType":"STK","nameCN":"生物医药","latestPrice":2037.27,"timestamp":1773990207000,"preClose":2072.24,"halted":0,"volume":358970162,"delay":0,"changeRate":-0.0169,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-34.97,"latestTime":"03-20 15:00:00","open":2072.04,"high":2093.45,"low":2036.99,"amount":11403000000,"amplitude":0.0272,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":5,"adr":0,"adjPreClose":2072.24,"symbolType":"index","openAndCloseTimeList":[[1773970200000,1773977400000],[1773982800000,1773990000000]],"highLimit":0,"lowLimit":0,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/399441","defaultTab":"news","newsList":[{"id":"2621506287","title":"聚焦钢铁、化工、生物医药等重点行业 河北将培育一批工业大模型","url":"https://stock-news.laohu8.com/highlight/detail?id=2621506287","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621506287?lang=zh_cn&edition=full","pubTime":"2026-03-21 06:57","pubTimestamp":1774047420,"startTime":"0","endTime":"0","summary":"在化工行业,河北聚焦安全生产、工艺控制、配方优化、环保监测等场景,培育智能控制大模型、安全预警大模型。在生物医药行业,河北针对药物研发、质量追溯、生产管控、临床辅助等场景,培育药物研发大模型、智能质检大模型。在机器人行业,河北针对运动控制、视觉识别、人机协作、自主决策等场景,培育运动控制大模型、多模态感知大模型。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-03-21/doc-inhrswxz7526058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399441","BK4585","XBI","BK4581","BK4588","161726"],"gpt_icon":0},{"id":"2620209854","title":"派格生物医药-B涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620209854","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620209854?lang=zh_cn&edition=full","pubTime":"2026-03-20 10:51","pubTimestamp":1773975087,"startTime":"0","endTime":"0","summary":"每经AI快讯,3月20日,派格生物医药-B(02565.HK)涨超10%,截至发稿,涨10.21%,报61.55港元,成交额2519.24万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603203678545515.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603203678545515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","XBI","161726","BK4588","399441","BK1161","BK4581","02565"],"gpt_icon":0},{"id":"2620203185","title":"【券商聚焦】中国银河:“十五五”首次将生物医药列为国家新兴支柱产业,持续发力研发创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2620203185","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620203185?lang=zh_cn&edition=full","pubTime":"2026-03-20 09:23","pubTimestamp":1773969824,"startTime":"0","endTime":"0","summary":"“十四五”规划重点关注医药创新产品产业化、医药产业化技术攻关、疫苗和短缺药品供应保障、产品质量升级、医药工业绿色低碳等五大工程,成效斐然,中国创新药获批上市数量由2015年的11款提升至2024年的92款,2024年共有22款国产化药和17款国产生物药获批上市,国产创新药占比提升至42%。“十五五”规划提出健全医疗、医保、医药协同发展和治理机制,生物医药产业首次被列为国家“新兴支柱产业”,战略定位进一步提升。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976888","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","02696","161726","BK1141","BK1147","IE00B543WZ88.USD","LU0348767384.USD","SG9999014674.SGD","LU2778985437.USD","BK4581","LU1969619763.USD","LU0561508036.HKD","LU2476274720.SGD","LU2476274308.USD","BK4585","HK0000306701.USD","06160","HK0000306685.HKD","LU2045819591.USD","LU0196878994.USD","LU0417516571.SGD","BK4588","399441","LU0348766576.USD","LU2125910500.SGD","09926","LU0348735423.USD","LU0307460666.USD","LU0348825331.USD","BK1588","HK0000320223.HKD","LU0588546209.SGD","BK1564","02359","601881","LU0708995583.HKD","06990","09995","LU1720050803.USD","BK1161","LU2328871848.SGD","LU0052750758.USD","BK0276","LU0540923850.HKD","LU2242644610.SGD","06881","LU1770034418.SGD","XBI","02268"],"gpt_icon":0},{"id":"2620840382","title":"中华医学会副会长杨宝峰:生物医药发展需要多学科交叉,AI也是助手","url":"https://stock-news.laohu8.com/highlight/detail?id=2620840382","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620840382?lang=zh_cn&edition=full","pubTime":"2026-03-18 14:10","pubTimestamp":1773814200,"startTime":"0","endTime":"0","summary":"中国工程院院士、中华医学会副会长杨宝峰表示,总的来讲,生物医药发展的前景可以说是在健康领域,未来是在慢病、恶性肿瘤,还有心脑血管系统疾病、呼吸系统疾病等,但是需要多学科交叉,AI也是助手。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/china/2026-03-18/doc-inhrkwsq1512328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK4581","XBI","399441","161726","BK4588"],"gpt_icon":0},{"id":"2619454015","title":"派格生物医药-B(02565)与腾瑞制药达成派达康中国大陆独家商业化合作 商业化目标累计销售规模超过100亿元并获得约1.4亿港元权益金","url":"https://stock-news.laohu8.com/highlight/detail?id=2619454015","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619454015?lang=zh_cn&edition=full","pubTime":"2026-03-16 18:52","pubTimestamp":1773658322,"startTime":"0","endTime":"0","summary":"智通财经APP讯,派格生物医药-B 发布公告,近日与上海腾瑞制药股份有限公司就本公司核心产品派达康在中国大陆地区的商业化合作签署战略合作协议。双方在合作协议中确立以实现累计销售规模超过人民币 100亿元作为核心商业化目标。根据合作协议,腾瑞制药将向本公司支付合计约1.4亿港币的权益金。根据合作安排,腾瑞制药将负责目标产品在中国大陆地区的独家商业化推广活动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02565","01477","399441","161726","BK1161","BK4585","BK4588","BK1191","BK4581","BK1574","XBI"],"gpt_icon":0},{"id":"2619143043","title":"从“新兴”到“支柱” 生物医药产业能级跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2619143043","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619143043?lang=zh_cn&edition=full","pubTime":"2026-03-14 04:17","pubTimestamp":1773433049,"startTime":"0","endTime":"0","summary":"“这是国家战略层面的关键跃升,标志着该产业正式进入经济增长的核心主序列。”3月7日,在京出席全国两会的全国政协委员、复旦大学上海医学院副院长朱同玉在大会结束后接受《中国经营报》记者采访时,这样说道。今年的《政府工作报告》中,生物医药被首次定位为“新兴支柱产业”,与集成电路、航空航天、低空经济等产业并列。过去,生物医药作为保障民生的配套产业,被定位为“新兴产业”进行培育。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603143671949650.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["399441","161726","XBI","BK4581","BK4588","BK4585"],"gpt_icon":0},{"id":"2618931050","title":"派格生物医药-B(02565)每手买卖单位将更改为50股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618931050","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618931050?lang=zh_cn&edition=full","pubTime":"2026-03-10 18:55","pubTimestamp":1773140138,"startTime":"0","endTime":"0","summary":"智通财经APP讯,派格生物医药-B(02565)发布公告,公司股本中每股面值人民币1.00元的H股于香港联合交易所有限公司(联交所)主板买卖的每手买卖单位将由500股H股更改为50股H股,自2026年3月31日(星期二)上午九时正起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","161726","BK4581","XBI","02565","BK4588","BK4585","399441"],"gpt_icon":0},{"id":"2617685492","title":"派格生物医药-B(02565):派格生物新一代GLP-1(CR059)首次人体试验取得一个月临床观察结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2617685492","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617685492?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:04","pubTimestamp":1772787852,"startTime":"0","endTime":"0","summary":"派格生物医药-B(02565)发布公告,公司基于环状RNA(CircRNA)蛋白替代技术并结合人工智能辅助分子设计平台自主研发的新一代GLP-1受体激动剂CR059,为PB-2309三受体(GLP-1/GIP/GCG)激动剂项目分阶段开发策略中针对GLP-1受体激动机制进行先行临床验证的候选产品,已于受试者中完成单次给药并取得一个月人体临床观察结果。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_48.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_48.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4144","GLP","399441","BK4590","BK4588","161726","BK4585","LABU","BK1161","02565"],"gpt_icon":0},{"id":"2616987005","title":"兰州高新区生物医药产业冲刺首季“开门红”","url":"https://stock-news.laohu8.com/highlight/detail?id=2616987005","media":"每日甘肃网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616987005?lang=zh_cn&edition=full","pubTime":"2026-03-02 08:52","pubTimestamp":1772412720,"startTime":"0","endTime":"0","summary":"攻坚核心技术优化产业生态兰州高新区生物医药产业冲刺首季“开门红” 近日,记者走进兰州高新区国家生物医药产业基地,映入眼帘的是一派繁忙景象:实验室内科研人员专注操作精密仪器,生产车间里自动化生产线满负荷运转……在这个生机勃发的早春,兰州高新区正以“满格”状态冲刺新年“开门红”,为全年高质量发展蓄势赋能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-03-02/doc-inhppxwt4806959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","LABU","161726","BK4585","399441"],"gpt_icon":0},{"id":"2614501352","title":"四川双马:持续推进生物医药板块的深度布局与高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2614501352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614501352?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:33","pubTimestamp":1772094795,"startTime":"0","endTime":"0","summary":"四川双马回复:您好,近年来,公司业务已基本成型,形成了以投资带产业的发展模式,基金投资布局科创领域、战略新兴产业等,并通过直投和投资孵化器平台的方式布局了生物医药等科创领域,进一步优化业务布局,拓宽发展空间,整体经营活力与发展潜力持续提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600024275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0021","000935","BK0028","BK0004","161726","399441","BK0235"],"gpt_icon":0},{"id":"2614805743","title":"天辰生物医药再度递表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2614805743","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614805743?lang=zh_cn&edition=full","pubTime":"2026-02-26 06:31","pubTimestamp":1772058660,"startTime":"0","endTime":"0","summary":"据港交所2月25日披露,天辰生物医药(苏州)股份有限公司(简称:天辰生物医药)向港交所主板递交上市申请,国金证券(香港)为独家保荐人。该公司曾于2025年8月21日递表港交所。招股书显示,天辰 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260226/c674918194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["161726","399441"],"gpt_icon":0},{"id":"2613762557","title":"生物医药企业Polaryx直接上市:市值1.24亿美元 9个月净亏749万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613762557","media":"雷递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613762557?lang=zh_cn&edition=full","pubTime":"2026-02-23 22:16","pubTimestamp":1771856160,"startTime":"0","endTime":"0","summary":"雷递网 雷建平 2月23日生物医药企业Polaryx Therapeutics日前在美国纳斯达克直接上市,截至目前,公司市值为1.24亿美元。Polaryx主要产品候选PLX-200针对多种LSDs,正在进入临床试验阶段。Polaryx的药物开发战略致力于提供安全、有效和患者友好的治疗方案,以满足这些疾病的重大未满足需求。Polaryx准备在2026年上半年启动SOTERIA试验。Polaryx在2023年、2024年净亏损分别为378万美元、3036万美元;2025年前9个月净亏损为749万美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MjM5MzQ5NjIyMQ==&mid=2661666034&idx=5&sn=e58d294c1a50415d06f935294752ef10&chksm=bdc741008ab0c81652a121815cd0950ba41e70114cb208f0968d211a054f17b83e28e236e856#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["161726","399441"],"gpt_icon":0},{"id":"2612266839","title":"生物医药企业Polaryx直接上市:市值1.26亿美元 9个月亏749万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612266839","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612266839?lang=zh_cn&edition=full","pubTime":"2026-02-20 18:42","pubTimestamp":1771584176,"startTime":"0","endTime":"0","summary":"生物医药企业Polaryx Therapeutics(股票代码:“PLYX”)日前在美国纳斯达克直接上市,截至目前,公司市值为1.26亿美元。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260220/6390720976347670688886744.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260220/6390720976347670688886744.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n32697/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["161726","BK4588","399441","BK4585","LABU"],"gpt_icon":0},{"id":"2611118298","title":"大兴机场临空区,国际生物医药园(二期)冲出正负零","url":"https://stock-news.laohu8.com/highlight/detail?id=2611118298","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611118298?lang=zh_cn&edition=full","pubTime":"2026-02-14 12:39","pubTimestamp":1771043940,"startTime":"0","endTime":"0","summary":"新京报讯 据“这里是大兴”微信公众号消息,大兴机场综保区内,随着最后一方混凝土浇筑完成,国际生物医药园 项目顺利冲出正负零建设节点,迈入主体结构施工新阶段。作为临空区投运的首个生物医药标厂项目,综保区国际生物医药园(一期)自2023年投入运营以来,凭借综保区特有的保税研发、保税生产等政策优势,已初步形成产业集聚。","market":"hk","thumbnail":"https://media.bjnews.com.cn/cover/2026/02/14/5686710861528375996.jpeg?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/02/14/5686710861528375996.jpeg?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1771041749129846.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1771041749129846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["161726","BK4588","BK4585","LABU","399441"],"gpt_icon":0},{"id":"2611811855","title":"派格生物医药-B股价下跌5.54%,受板块走弱及利好兑现影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2611811855","media":"经济观察网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611811855?lang=zh_cn&edition=full","pubTime":"2026-02-14 12:07","pubTimestamp":1771042020,"startTime":"0","endTime":"0","summary":"经济观察网 派格生物医药-B(02565.HK)股价于2月13日下跌5.54%,收报63.05港元。此次下跌主要受市场整体走弱、纳入指数利好兑现、技术面承压、资金面分歧及高估值压力等多重因素影响。股票 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260214/c674819133.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260214/c674819133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["161726","399441"],"gpt_icon":0},{"id":"2611191505","title":"派格生物医药-B获纳入恒生综合指数 有望成为港股通标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2611191505","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611191505?lang=zh_cn&edition=full","pubTime":"2026-02-14 08:01","pubTimestamp":1771027260,"startTime":"0","endTime":"0","summary":"2月13日,恒生指数公司宣布截至2025年12月31日之恒生指数系列季度检讨结果,其中派格生物医药-B(02565)获纳入恒生综合指数。变动将于2026年3月6日(星期五)收市后实施并于2026年3月9日(星期 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260214/c674813797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["161726","399441"],"gpt_icon":0},{"id":"2609309248","title":"成大生物(688739)披露拟参与设立5.02亿元生物医药产业投资基金,2月5日股价上涨0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609309248","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609309248?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:26","pubTimestamp":1770301580,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘,成大生物报收于25.89元,较前一交易日上涨0.39%,最新总市值为107.82亿元。该股当日开盘25.8元,最高26.07元,最低25.71元,成交额达5943.37万元,换手率为0.55%。近日,辽宁成大生物股份有限公司披露《2026年第一次临时股东会会议资料》。公告显示,公司拟与控股股东辽宁成大及其全资子公司共同发起设立成大生物医药产业投资基金,基金设立规模为50,200万元,公司作为有限合伙人认缴出资4亿元。本次事项构成关联交易,需提交股东大会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","BK0239","688739","399441"],"gpt_icon":0},{"id":"1197197181","title":"港股生物医药板块走高,诺诚健华、再鼎医药涨超4%,药明康德、药明生物等个股跟涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1197197181","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197197181?lang=zh_cn&edition=full","pubTime":"2026-02-05 15:24","pubTimestamp":1770276262,"startTime":"0","endTime":"0","summary":"2月5日,港股$生物(000504)$医药板块走高,$诺诚健华(09969)$、$再鼎医药(09688)$涨超4%,$药明康德(02359)$、$药明$生物(000504)$(02269)$等个股跟涨。","market":"hk","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4d7f9f320a213719065b5b2c9bc96e8b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399441","LU0359201612.USD","LU0819121731.USD","BK0239","LU0417516738.SGD","LU1242518857.USD","LU1720050803.USD","SG9999002562.SGD","BK1588","BK1589","LU1880383366.USD","LU0326950275.SGD","09688","LU1046422090.SGD","LU2125910500.SGD","BK1610","LU0516422366.SGD","LU0320764599.SGD","LU0456846285.SGD","LU3063872942.SGD","IE00B0JY6N72.USD","02359","LU0052750758.USD","LU2045819591.USD","BK1576","LU2039709279.SGD","LU0823426308.USD","LU2328871848.SGD","SG9999002463.SGD","BK4548","LU2242644610.SGD","LU0588546209.SGD","LU1997245177.USD","LU0516423091.SGD","LU1242518931.SGD","LU0572944931.SGD","LU1997245094.SGD","LU0708995583.HKD","BK0216","LU1934453819.USD","LU0516422952.EUR","LU0359202008.SGD","LU0140636845.USD","BK4585","LU0516423174.USD","LU2488822045.USD","LU0417516902.SGD","09969","LU1794554557.SGD","BK1521","BK1141","LU0456842615.SGD","LU1979443071.USD","BK4588","LU0327786744.USD","BK4531","BK4526","LU0516422440.USD","LU0307460666.USD","BK1161","LU0348825331.USD","LU0348735423.USD","LU1997244956.HKD","LU0051755006.USD","BK1583","LU0823426480.USD","BK4139","LU0979878070.USD","LU0456827905.SGD","BK1574","LU1688375341.USD","LU2495084118.USD","LU0181495838.USD","LU0043850808.USD","LU0856984785.SGD","LU1808992512.USD","02269","LU0039217434.USD","LU1969619763.USD"],"gpt_icon":0},{"id":"2608851131","title":"2月2日长春高新跌6.14%,招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608851131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608851131?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:47","pubTimestamp":1770022049,"startTime":"0","endTime":"0","summary":"证券之星消息,2月2日长春高新跌6.14%创60日新低,收盘报90.01元,换手率2.73%,成交量10.9万手,成交额9.9亿元。重仓长春高新的前十大公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共31家,其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为14.39亿元,最新净值0.4035,较上一交易日下跌0.98%,近一年上涨12.43%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000661","161726","BK0028","BK0188","BK0239","399441","BK0057","BK0075","BK0046"],"gpt_icon":0},{"id":"2607224157","title":"天溯计量:此次获奖项目是公司针对生物医药开展的具有原创性的计量装置研发与应用实践","url":"https://stock-news.laohu8.com/highlight/detail?id=2607224157","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607224157?lang=zh_cn&edition=full","pubTime":"2026-01-29 08:39","pubTimestamp":1769647150,"startTime":"0","endTime":"0","summary":"证券之星消息,天溯计量(301449)01月28日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘您好!贵司《基于多加速度传感器的医用离心机转速校准方法研究及装置研发》荣获“技术创新奖”二等奖,请问传感器领域是否形成营收?知名客户有哪些?感谢回复!祝您生活愉快天溯计量回复:尊敬的投资者您好,感谢您的提问。此次获奖项目是公司针对生物医药开展的具有原创性的计量装置研发与应用实践。公司与客户的合作信息请以公司披露的信息为准。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900006680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","BK0221","301449","399441"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774176622212,"stockEarnings":[{"period":"1week","weight":-0.0232},{"period":"1month","weight":-0.0628},{"period":"3month","weight":-0.0697},{"period":"6month","weight":-0.186},{"period":"1year","weight":-0.0378},{"period":"ytd","weight":-0.0506}],"compareEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":-0.0306},{"period":"3month","weight":0.0171},{"period":"6month","weight":0.0359},{"period":"1year","weight":0.1608},{"period":"ytd","weight":-0.003}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物医药,399441,生物医药股票,生物医药股票老虎,生物医药股票老虎国际,生物医药行情,生物医药股票行情,生物医药股价,生物医药股市,生物医药股票价格,生物医药股票交易,生物医药股票购买,生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}